Molecular Pathways: How Can BRCA-Mutated Tumors Become Resistant to PARP Inhibitors?
Year: 2013
Type: review
Source: Clinical Cancer Research
Authors: Peter Bouwman, Jos Jonkers
Institution: The Netherlands Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2102967423
